We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CONXW
12501
DELISTED
CONX Corp. Warrant
CONXW
$23K ﹤0.01%
53,318
ACGN
12502
CALL
DELISTED
Aceragen Inc
ACGN
$23K ﹤0.01%
2,679
+812
+43% +$7.34K
SIOX
12503
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$23K ﹤0.01%
34,900
-25,600
-42% -$21.7K
OBSV
12504
CALL
DELISTED
ObsEva SA Ordinary Shares
OBSV
$23K ﹤0.01%
15,000
-118,400
-89% -$175K
UPH
12505
CALL
DELISTED
UpHealth, Inc.
UPH
$23K ﹤0.01%
+1,980
New +$43.8K
CALA
12506
CALL
DELISTED
Calithera Biosciences, Inc
CALA
$23K ﹤0.01%
2,875
-55
-2% -$562
EVOL
12507
DELISTED
Evolving Systems, Inc.
EVOL
$23K ﹤0.01%
12,567
+1,593
+15% +$3.07K
BBGI icon
12508
Beasley Broadcasting Group
BBGI
$36.6M
$22K ﹤0.01%
634
-4,028
-86% -$151K
CYCN icon
12509
Cyclerion Therapeutics
CYCN
$19.2M
$22K ﹤0.01%
992
-404
-29% -$9.73K
GRNQ icon
12510
Greenpro Capital
GRNQ
$23.7M
$22K ﹤0.01%
+505
New +$23K
MSN icon
12511
Emerson Radio
MSN
$10.1M
$22K ﹤0.01%
28,771
+4,020
+16% +$3.04K
TWAV
12512
TaoWeave Inc
TWAV
$5.35M
$22K ﹤0.01%
57
+14
+33% +$6.24K
CSCI
12513
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$22K ﹤0.01%
587
+429
+272% +$15.4K
SCTL
12514
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$22K ﹤0.01%
11,994
-7,173
-37% -$12.4K
SPPI
12515
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$22K ﹤0.01%
17,000
-96,200
-85% -$88.6K
NYMX
12516
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
$22K ﹤0.01%
+17,200
New +$26.6K
HZON.WS
12517
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
$22K ﹤0.01%
33,333
LCI
12518
PUT
DELISTED
Lannett Company, Inc.
LCI
$22K ﹤0.01%
6,875
-40,925
-86% -$180K
NBEV
12519
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$22K ﹤0.01%
37,700
-8,800
-19% -$6.3K
BSQR
12520
PUT
DELISTED
BSQUARE Corporation
BSQR
$22K ﹤0.01%
12,800
-101,700
-89% -$167K
CKPT
12521
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$21K ﹤0.01%
1,170
-980
-46% -$21K
WVE icon
12522
CALL
Wave Life Sciences
WVE
$1B
$21K ﹤0.01%
10,600
-2,300
-18% -$5.63K
TRAW icon
12523
CALL
Traws Pharma
TRAW
$9.12M
$21K ﹤0.01%
448
-716
-62% -$33.2K
ABVEW
12524
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$21K ﹤0.01%
61,669
+23,782
+63% +$10.1K
PIXY
12525
CALL
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$21K ﹤0.01%
+1
New +$35.5K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.